Is it a good or bad time for a health-tech company to raise?
With HTN, we surveyed 150 investors, founders & operators on the 'New Normal' - here's the results
This is a co-written piece with HTN’s Ryan Russell and Kevin O’Leary
TL;DR: With the overall market going bananas and a potential recession looming, there is a lot of speculation on the impact to the private health tech market. So we, HTN and OMERS Ventures, have teamed up to survey ~150 health care startup operators and investors for perspectives on changing conditions. Some of these observations may seem obvious to many of you, but we saw a need for a more quantitative (admittedly unscientific) analysis. And we made the survey anonymous, so recipients could speak their minds.
Here were some takeaways that we’ll dive deeper into below:
Growth stage companies appear to be changing course quickly - most are pivoting away from revenue growth to profitability and are, at the very least, slowing down hiring seemingly driven by a concern that it could be a while until they see an exit or another round of capital that isn’t overly dilutive)
Early stage companies appear to be business as usual …